300 research outputs found

    Nitrogenase Iron Protein Classification using CNN Neural Network

    Get PDF
    The nitrogenase iron protein (NifH) is extensively used to study nitrogen fixation, the ecologically vital process of reducing atmospheric nitrogen to a bioavailable form. The discovery rate of novel NifH sequences is high, and there is an ongoing need for software tools to mine NifH records from the GenBank repository. Since record annotations are unreliable, because they contain errors, classifiers based on sequence alone are required. The ARBitrator classifier is highly successful but must be initialized by extensive manual effort. A Deep Learning approach could substantially reduce manual intervention. However, attempts to build a character-based Deep Learning NifH classifier were unsuccessful. We hypothesized that we could generate visual representations of protein sequences and use a Convolutional Neural Network to classify the representations. Here we present the resulting classifier, which has achieved false positive and false negative rates of 0.19% and 0.22%, respectively

    Deep Learning Methods for Protein Family Classification on PDB Sequencing Data

    Full text link
    Composed of amino acid chains that influence how they fold and thus dictating their function and features, proteins are a class of macromolecules that play a central role in major biological processes and are required for the structure, function, and regulation of the body's tissues. Understanding protein functions is vital to the development of therapeutics and precision medicine, and hence the ability to classify proteins and their functions based on measurable features is crucial; indeed, the automatic inference of a protein's properties from its sequence of amino acids, known as its primary structure, remains an important open problem within the field of bioinformatics, especially given the recent advancements in sequencing technologies and the extensive number of known but uncategorized proteins with unknown properties. In this work, we demonstrate and compare the performance of several deep learning frameworks, including novel bi-directional LSTM and convolutional models, on widely available sequencing data from the Protein Data Bank (PDB) of the Research Collaboratory for Structural Bioinformatics (RCSB), as well as benchmark this performance against classical machine learning approaches, including k-nearest neighbors and multinomial regression classifiers, trained on experimental data. Our results show that our deep learning models deliver superior performance to classical machine learning methods, with the convolutional architecture providing the most impressive inference performance

    Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches

    Get PDF
    Drug Safety (DS) is a domain with significant public health and social impact. Knowledge Engineering (KE) is the Computer Science discipline elaborating on methods and tools for developing “knowledge-intensive” systems, depending on a conceptual “knowledge” schema and some kind of “reasoning” process. The present systematic and mapping review aims to investigate KE-based approaches employed for DS and highlight the introduced added value as well as trends and possible gaps in the domain. Journal articles published between 2006 and 2017 were retrieved from PubMed/MEDLINE and Web of Science® (873 in total) and filtered based on a comprehensive set of inclusion/exclusion criteria. The 80 finally selected articles were reviewed on full-text, while the mapping process relied on a set of concrete criteria (concerning specific KE and DS core activities, special DS topics, employed data sources, reference ontologies/terminologies, and computational methods, etc.). The analysis results are publicly available as online interactive analytics graphs. The review clearly depicted increased use of KE approaches for DS. The collected data illustrate the use of KE for various DS aspects, such as Adverse Drug Event (ADE) information collection, detection, and assessment. Moreover, the quantified analysis of using KE for the respective DS core activities highlighted room for intensifying research on KE for ADE monitoring, prevention and reporting. Finally, the assessed use of the various data sources for DS special topics demonstrated extensive use of dominant data sources for DS surveillance, i.e., Spontaneous Reporting Systems, but also increasing interest in the use of emerging data sources, e.g., observational healthcare databases, biochemical/genetic databases, and social media. Various exemplar applications were identified with promising results, e.g., improvement in Adverse Drug Reaction (ADR) prediction, detection of drug interactions, and novel ADE profiles related with specific mechanisms of action, etc. Nevertheless, since the reviewed studies mostly concerned proof-of-concept implementations, more intense research is required to increase the maturity level that is necessary for KE approaches to reach routine DS practice. In conclusion, we argue that efficiently addressing DS data analytics and management challenges requires the introduction of high-throughput KE-based methods for effective knowledge discovery and management, resulting ultimately, in the establishment of a continuous learning DS system

    OAE: The Ontology of Adverse Events

    Get PDF
    A medical intervention is a medical procedure or application intended to relieve or prevent illness or injury. Examples of medical interventions include vaccination and drug administration. After a medical intervention, adverse events (AEs) may occur which lie outside the intended consequences of the intervention. The representation and analysis of AEs are critical to the improvement of public health. Description: The Ontology of Adverse Events (OAE), previously named Adverse Event Ontology (AEO), is a community-driven ontology developed to standardize and integrate data relating to AEs arising subsequent to medical interventions, as well as to support computer-assisted reasoning. OAE has over 3,000 terms with unique identifiers, including terms imported from existing ontologies and more than 1,800 OAE-specific terms. In OAE, the term ‘adverse event’ denotes a pathological bodily process in a patient that occurs after a medical intervention. Causal adverse events are defined by OAE as those events that are causal consequences of a medical intervention. OAE represents various adverse events based on patient anatomic regions and clinical outcomes, including symptoms, signs, and abnormal processes. OAE has been used in the analysis of several different sorts of vaccine and drug adverse event data

    OAE: The Ontology of Adverse Events

    Get PDF
    A medical intervention is a medical procedure or application intended to relieve or prevent illness or injury. Examples of medical interventions include vaccination and drug administration. After a medical intervention, adverse events (AEs) may occur which lie outside the intended consequences of the intervention. The representation and analysis of AEs are critical to the improvement of public health. Description: The Ontology of Adverse Events (OAE), previously named Adverse Event Ontology (AEO), is a community-driven ontology developed to standardize and integrate data relating to AEs arising subsequent to medical interventions, as well as to support computer-assisted reasoning. OAE has over 3,000 terms with unique identifiers, including terms imported from existing ontologies and more than 1,800 OAE-specific terms. In OAE, the term ‘adverse event’ denotes a pathological bodily process in a patient that occurs after a medical intervention. Causal adverse events are defined by OAE as those events that are causal consequences of a medical intervention. OAE represents various adverse events based on patient anatomic regions and clinical outcomes, including symptoms, signs, and abnormal processes. OAE has been used in the analysis of several different sorts of vaccine and drug adverse event data

    Biomedical informatics and translational medicine

    Get PDF
    Biomedical informatics involves a core set of methodologies that can provide a foundation for crossing the "translational barriers" associated with translational medicine. To this end, the fundamental aspects of biomedical informatics (e.g., bioinformatics, imaging informatics, clinical informatics, and public health informatics) may be essential in helping improve the ability to bring basic research findings to the bedside, evaluate the efficacy of interventions across communities, and enable the assessment of the eventual impact of translational medicine innovations on health policies. Here, a brief description is provided for a selection of key biomedical informatics topics (Decision Support, Natural Language Processing, Standards, Information Retrieval, and Electronic Health Records) and their relevance to translational medicine. Based on contributions and advancements in each of these topic areas, the article proposes that biomedical informatics practitioners ("biomedical informaticians") can be essential members of translational medicine teams

    OAE: The Ontology of Adverse Events

    Full text link

    Bayesian network learning and applications in Bioinformatics

    Get PDF
    Abstract A Bayesian network (BN) is a compact graphic representation of the probabilistic re- lationships among a set of random variables. The advantages of the BN formalism include its rigorous mathematical basis, the characteristics of locality both in knowl- edge representation and during inference, and the innate way to deal with uncertainty. Over the past decades, BNs have gained increasing interests in many areas, including bioinformatics which studies the mathematical and computing approaches to under- stand biological processes. In this thesis, I develop new methods for BN structure learning with applications to bi- ological network reconstruction and assessment. The first application is to reconstruct the genetic regulatory network (GRN), where each gene is modeled as a node and an edge indicates a regulatory relationship between two genes. In this task, we are given time-series microarray gene expression measurements for tens of thousands of genes, which can be modeled as true gene expressions mixed with noise in data generation, variability of the underlying biological systems etc. We develop a novel BN structure learning algorithm for reconstructing GRNs. The second application is to develop a BN method for protein-protein interaction (PPI) assessment. PPIs are the foundation of most biological mechanisms, and the knowl- edge on PPI provides one of the most valuable resources from which annotations of genes and proteins can be discovered. Experimentally, recently-developed high- throughput technologies have been carried out to reveal protein interactions in many organisms. However, high-throughput interaction data often contain a large number of iv spurious interactions. In this thesis, I develop a novel in silico model for PPI assess- ment. Our model is based on a BN that integrates heterogeneous data sources from different organisms. The main contributions are: 1. A new concept to depict the dynamic dependence relationships among random variables, which widely exist in biological processes, such as the relationships among genes and genes' products in regulatory networks and signaling pathways. This con- cept leads to a novel algorithm for dynamic Bayesian network learning. We apply it to time-series microarray gene expression data, and discover some missing links in a well-known regulatory pathway. Those new causal relationships between genes have been found supportive evidences in literature. 2. Discovery and theoretical proof of an asymptotic property of K2 algorithm ( a well-known efficient BN structure learning approach). This property has been used to identify Markov blankets (MB) in a Bayesian network, and further recover the BN structure. This hybrid algorithm is evaluated on a benchmark regulatory pathway, and obtains better results than some state-of-art Bayesian learning approaches. 3. A Bayesian network based integrative method which incorporates heterogeneous data sources from different organisms to predict protein-protein interactions (PPI) in a target organism. The framework is employed in human PPI prediction and in as- sessment of high-throughput PPI data. Furthermore, our experiments reveal some interesting biological results. 4. We introduce the learning of a TAN (Tree Augmented Naïve Bayes) based net- work, which has the computational simplicity and robustness to high-throughput PPI assessment. The empirical results show that our method outperforms naïve Bayes and a manual constructed Bayesian Network, additionally demonstrate sufficient informa- tion from model organisms can achieve high accuracy in PPI prediction
    corecore